---
title: "Unjha Formulations Ltd (531762) — Share Price, Financials & Analysis"
symbol: "531762"
company: "Unjha Formulations Ltd"
canonical: "https://tapetide.com/stocks/531762"
isin: "INE576D01015"
nse_symbol: "UNJHAFORMULATIONSLTD"
bse_code: "531762"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 15.1
generated_at: "2026-09-13T19:40:13.312Z"
---

# Unjha Formulations Ltd (531762)

Canonical page: https://tapetide.com/stocks/531762

## Company

- **NSE Symbol:** UNJHAFORMULATIONSLTD
- **BSE Code:** 531762
- **ISIN:** INE576D01015
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** unjhaformulations.com

## About

Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:56.433239Z.

- **Market Cap:** ₹15.1 Cr
- **Classification:** Microcap
- **P/E (reported):** 32.1
- **EPS (TTM):** ₹1.08
- **EPS (reported):** ₹1.78
- **Book Value:** ₹8.58
- **Price to Book:** 3.93
- **Dividend Yield:** 0%
- **ROE:** 18.34%
- **ROCE:** 25.02%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹15.7 Cr
- **Net Income:** ₹0.7 Cr
- **EBITDA:** ₹1.1 Cr
- **52-Week High:** ₹36.38
- **52-Week Low:** ₹17.52
- **RSI (14):** 68.7

## Tapetide Score

- **Score:** 61 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 90.4 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 76.34 | 9% |
| growth | 55.92 | 9% |
| momentum | 94.8 | 12% |
| ownership | 50 | 24% |
| quality | 68.95 | 22% |
| valuation | 47.73 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- The company has delivered a poor sales growth of 9.37% over past five years.
- Promoter holding is low: 36.9%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | 20.39% | 342.86% |
| ebitda margin growth | 150% | 55.43% | 121.14% | 98.02% |
| net income growth | 128.57% | 75% | 36% | 48% |
| revenue growth | 0% | 12.14% | 6% | 9% |
| roce | — | 47.96% | 35.32% | 19.22% |
| roe | — | 41.29% | 13.83% | 57.7% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.76 | 5.55 | 4.43 | 3.95 | 3.78 | 3.76 | 2.44 | 3.63 | 4.29 | 4.44 | 3.33 | 3.31 |
| Expenses | 4.87 | 5.14 | 4.37 | 3.23 | 3.89 | 3.52 | 2.7 | 3.21 | 3.5 | 4.16 | 3.78 | 3.12 |
| Operating Profit | -0.11 | 0.41 | 0.06 | 0.72 | -0.11 | 0.24 | -0.26 | 0.42 | 0.79 | 0.28 | -0.45 | 0.19 |
| OPM % | -2.31 | 7.39 | 1.35 | 18.23 | -2.91 | 6.38 | -10.66 | 11.57 | 18.41 | 6.31 | -13.51 | 5.74 |
| Other Income | 0.01 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -0.12 | 0.39 | 0 | 0.7 | -0.11 | 0.23 | -0.29 | 0.39 | 0.82 | 0.24 | -0.49 | 0.15 |
| Tax % | 0 | 0 | — | 0 | 0 | 0 | 41.38 | 0 | 0 | 0 | 51.02 | 0 |
| Net Profit | -0.12 | 0.39 | -0.18 | 0.7 | -0.11 | 0.22 | -0.41 | 0.39 | 0.82 | 0.24 | -0.74 | 0.16 |
| EPS in Rs | -0.27 | 0.87 | -0.4 | 1.56 | -0.25 | 0.49 | -0.92 | 0.87 | 1.83 | 0.54 | -1.65 | 0.36 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 11.3 | 11.28 | 10.59 | 9.96 | 14.16 | 13.15 | 18.5 | 13.86 | 15.59 | 15.37 |
| Expenses | 10.96 | 10.98 | 10.34 | 9.83 | 13.84 | 12.71 | 17.93 | 13.34 | 14.64 | 14.56 |
| Operating Profit | 0.34 | 0.3 | 0.25 | 0.13 | 0.32 | 0.44 | 0.57 | 0.52 | 0.95 | 0.81 |
| OPM % | 3.01 | 2.66 | 2.36 | 1.31 | 2.26 | 3.35 | 3.08 | 3.75 | 6.09 | 5.27 |
| Other Income | 0.04 | 0.1 | 0.26 | 0.22 | 0.19 | 0.03 | 0.01 | 0.11 | 0.16 | 0.06 |
| Interest | 0.02 | 0.01 | 0.12 | 0.17 | 0.13 | 0.06 | 0.05 | 0.01 | 0.01 | 0 |
| Depreciation | 0.1 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.1 | 0.14 | 0.15 |
| Profit before tax | 0.26 | 0.3 | 0.31 | 0.1 | 0.3 | 0.33 | 0.45 | 0.52 | 0.96 | 0.72 |
| Tax % | 0 | 0 | 0 | 0 | 16.67 | 15.15 | 40 | 23.08 | 26.04 | — |
| Net Profit | 0.26 | 0.3 | 0.31 | 0.1 | 0.25 | 0.28 | 0.28 | 0.41 | 0.7 | 0.48 |
| EPS in Rs | 0.58 | 0.67 | 0.69 | 0.22 | 0.56 | 0.62 | 0.62 | 0.92 | 1.56 | 1.08 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 |
| Reserves | -3.54 | -3.27 | -2.97 | -2.67 | -2.56 | -2.31 | -2.03 | -1.75 | -1.34 | -0.64 |
| Borrowings | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 2.79 | 2.75 | 2.15 | 1.9 | 1.61 | 1.28 | 0.96 | 2.2 | 1.42 | 1.67 |
| Total Liabilities | 3.78 | 3.96 | 3.66 | 3.71 | 3.53 | 3.45 | 3.41 | 4.93 | 4.56 | 5.51 |
| Fixed Assets | 1.22 | 1.16 | 1.12 | 1.14 | 1.12 | 1.07 | 1.1 | 1.12 | 1.2 | 1.3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2.56 | 2.8 | 2.54 | 2.57 | 2.41 | 2.38 | 2.31 | 3.81 | 3.36 | 4.21 |
| Total Assets | 3.78 | 3.96 | 3.66 | 3.71 | 3.53 | 3.45 | 3.41 | 4.93 | 4.56 | 5.51 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.39 | 0.14 | -0.12 | 0.39 | -0.7 | 0.28 | -0.26 | 1.03 | -0.04 | 1.24 |
| Cash from Investing Activity | -0.28 | 0.06 | 0.04 | -0.1 | -0.06 | -0.02 | -0.1 | -0.11 | -0.18 | -0.23 |
| Cash from Financing Activity | 0.05 | -0.05 | 0.23 | 0 | 0 | 0 | -0.06 | -0.05 | -0.01 | -0.01 |
| Net Cash Flow | 0.15 | 0.15 | 0.16 | 0.29 | -0.77 | 0.25 | -0.42 | 0.86 | -0.23 | 1 |
| Free Cash Flow | 0.11 | 0.2 | -0.08 | 0.29 | -0.76 | 0.26 | -0.36 | 0.92 | -0.22 | 1.01 |
| CFO/OP | 105 | 41 | -37 | 204 | -408 | 88 | -48 | 189 | 19 | 156 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 19.4 | 25.19 | 43.36 | 39.64 | 35.91 | 18.04 | 29.14 | 31.76 | 39.77 | 31.61 |
| Inventory Days | 40.83 | 39.4 | 22.92 | 21.37 | 55.6 | 34.08 | 38.92 | 29.56 | 32.92 | 19.1 |
| Days Payable | 98.2 | 106.22 | 87.5 | 82.79 | 77.35 | 39.81 | 32.1 | 47.85 | 37.39 | 39.71 |
| Cash Conversion Cycle | -37.97 | -41.63 | -21.22 | -21.79 | 14.16 | 12.31 | 35.97 | 13.47 | 35.29 | 10.99 |
| Working Capital Days | -24.17 | -21.96 | -8.41 | -9.31 | 22.72 | 17.27 | 37.19 | 14.6 | 34.24 | 21.31 |
| ROCE % | 47.56 | 25.45 | 22.79 | 25.9 | 14.48 | 21.03 | 16.88 | 19.31 | 18.06 | 27.79 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% | 36.92% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 59.33% | 59.14% | 58.13% | 57.78% | 56.9% | 56.61% | 56.8% | 56.1% | 56.19% | 56.14% | 55.53% | 55.48% |
| Others | 3.74% | 3.94% | 4.95% | 5.3% | 6.17% | 6.47% | 6.28% | 6.98% | 6.88% | 6.94% | 7.54% | 7.6% |
| No. of Shareholders | 3993 | 4012 | 3933 | 3985 | 3969 | 4208 | 4273 | 4213 | 4284 | 4251 | 4235 | 4223 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 31.13 | Buy |
| EMA (10) | 31.6 | Buy |
| SMA (20) | 28.56 | Buy |
| EMA (20) | 29.64 | Buy |
| SMA (50) | 26.52 | Buy |
| EMA (50) | 26.81 | Buy |
| SMA (100) | 23.19 | Buy |
| EMA (100) | 24.77 | Buy |
| SMA (200) | 22.92 | Buy |
| EMA (200) | 23.72 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 68.7 | Neutral |
| MACD (12,26,9) | 2.22 | Buy |
| Stochastic (14,3,3) | 84.95 | Sell |
| ADX (14) | 20.12 | Neutral |
| Williams %R (14) | -22.92 | Neutral |
| ATR (14) | 1.48 | High Volatility |
| ROC (12) | 29.54 | Buy |
| Stoch RSI (14) | 70.45 | Neutral |
| UO (7,14,28) | 71.98 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1eb97cb-b7df-4963-b15c-2ca76de390d2.pdf) |
| 2026-09-08 | [Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8c64f66-c205-4a95-8e56-a1c3325e1582.pdf) |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a0701c1-13cc-46fd-92f3-9cdbb6d5e68d.pdf) |
| 2026-08-14 | [Cash Flow Statement For The Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8435c5d3-ebe4-4de7-9140-57f69cedabfa.pdf) |
| 2026-08-14 | [Cash Flow Statement For The Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0589a6e4-99f2-43a3-9f31-4261350ee8bb.pdf) |
| 2026-08-14 | [Filing Of Distribution Schedule](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b716ae59-178c-498b-8d6d-c0601300e5b2.pdf) |
| 2026-08-14 | [Regulation (30) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations2015 Details Of Voting Results At The 32Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71b557ee-3b85-4b04-b1f0-5f140cde1dab.pdf) |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=284129c0-119f-44a2-927b-584637f7c538.pdf) |
| 2026-08-05 | [Publish Audited Financial Results For The Quarter And Year Ended As On 30/06/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a10c7ea2-4d45-49bf-b95d-4156fa36d2d8.pdf) |
| 2026-08-03 | [Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2026 And Out Come Of Board Meeting Held On 3Rd August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c45f2f81-da21-475a-b9cd-74a986d6cb32.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-03 | [Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2026 And Out Come Of Board Meeting Held On 3Rd August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d177d401-3ba0-452b-9160-5399d09de4ce.pdf) |
| 2026-02-04 | [Approval Of Un-Audited Financial Results Of The Company For 9 Month And Quarter Ended On 31St December2025 And Out Come Of Board Meeting Held On 4Th February 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70f4c606-a671-4254-8531-487a7080b840.pdf) |
| 2025-11-10 | [Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September2025 And Out Come Of Board Meeting Held On 10Th November 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ebf874f-79ea-4dcb-8fc0-88c1810f1779.pdf) |
| 2025-08-06 | [Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June 2025 And Out Come Of Board Meeting Held On 6Th August 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=befef5fd-9b40-4ec4-bf59-4b31b3cd2b9f.pdf) |
| 2025-05-16 | [Approval Of Audited Financial Results Of The Company For Quarter Ended And Year Ended 31St March2025 And Out Come Of Board Meeting Held On 16.05.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdb47eba-8cea-4691-b433-f1e409593167.pdf) |
| 2025-02-04 | [Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Nine Month Ended On 31St December2024 And Out Come Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01bd5280-6066-483c-9e4b-600eb36419bc.pdf) |
| 2024-11-08 | [Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September,2024 And Out Come Of Board Meeting Held On 8Th, November ,2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43f0e629-89f1-48f5-aab0-2217c8022189.pdf) |
| 2024-08-01 | [Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June ,2024 And Out Come Of Board Meeting Held On 1ST,August ,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=030d4bac-232e-4ef1-baab-b559e53a10ac.pdf) |
| 2024-05-17 | [Approval Of Audited Financial Results Of The Company For Quarter Ended And Year Ended 31St March,2024 , And Out Come Of Board Meeting Held On 17.05.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff13cc83-20e2-486a-bc24-7f1c50412f1d.pdf) |
| 2024-01-29 | [Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Nine Month Ended On 31St December,2023 And Out Come Of Board Meeting Held On 29Th, January ,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0867427-562a-4e49-aa65-cb9c7bbf0bfb.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Assistant Commissioner confirmed Rs36,04,971 tax, Rs36,04,971 penalty, interest for FY2017-18; company will appeal. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('Listing Regulations') 9 Feb - Assistant Commissioner confirmed Rs36,04,971 tax, Rs36,04,971 penalty, interest for FY2017-18; company will appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18168095-396f-4afa-bdd5-2a03c301b78a.pdf) |
| 7h - Postal ballot to re-appoint Ameeta Chatterjee as Independent Director Apr 17,2026–Apr 16,2031; e-voting ends Apr 4,2026. | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 7h - Postal ballot to re-appoint Ameeta Chatterjee as Independent Director Apr 17,2026–Apr 16,2031; e-voting ends Apr 4,2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/511c64eb-443d-4f73-ad76-c0aba16da16d.pdf) |
| 5h - Submission of copies of newspaper advertisements for Postal Ballot | [Announcement under Regulation 30 (LODR)-Newspaper Publication 5h - Submission of copies of newspaper advertisements for Postal Ballot](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fc988d19-d5f6-43f0-8fd5-2554b1bc3a89.pdf) |
| 5 Feb - Surat builder Tushar Ghelani shot himself Feb 1; 9mm bullet through brain; condition critical at Mahavir Hospital. | [:Publish Un-Audited Financial Results For The Quarter & Nine Month Ended As On 31/12/2025 5 Feb - Surat builder Tushar Ghelani shot himself Feb 1; 9mm bullet through brain; condition critical at Mahavir Hospital.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4f732513-46c3-413c-b72c-aef7ac675c93.pdf) |
| 5 Feb - Presentation on financial and operational performance of the Company for the quarter ended December 31, 2025 | [Announcement under Regulation 30 (LODR)-Investor Presentation 5 Feb - Presentation on financial and operational performance of the Company for the quarter ended December 31, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de7228aa-44e8-4fb3-984c-890daa9f6772.pdf) |
| 4 Feb - Board approved unaudited Q3 and nine-month results for period ended 31-Dec-2025; limited review attached. | [Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For 9 Month And Quarter Ended On 31St December,2025 And Out Come Of Board Meeting Held On 4Th, February ,2025. 4 Feb - Board approved unaudited Q3 and nine-month results for period ended 31-Dec-2025; limited review attached.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fc67c5a6-32cf-48b0-b6de-22977b860c0d.pdf) |
| 22 Apr - Board meeting on 18 May 2026 to approve audited results for year ended 31 March 2026 and appoint secretarial auditor. | [Board Meeting Intimation for Board Meeting - Date: 18.05.2026 (AUDITED FINANCIAL RESULTS AS ON 31/03/2026) 22 Apr - Board meeting on 18 May 2026 to approve audited results for year ended 31 March 2026 and appoint secretarial auditor.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d4331257-8123-4a9a-8002-237c356f03ca.pdf) |
| 20 Jan - Board meeting on 04.02.2026 to consider un-audited results for nine months ended 31.12.2025. | [Board Meeting Intimation for Board Meeting - Date: 04.02.2026 (Un-Audited Financial Results For The Ninth Month Ended On 31.12.2025) 20 Jan - Board meeting on 04.02.2026 to consider un-audited results for nine months ended 31.12.2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d3a7b419-60d1-4cf6-a6f4-383a37acac3a.pdf) |
| 2 Apr - Trading window closed from 1 April 2026 until 48 hours after FY26 audited results. | [Closure of Trading Window 2 Apr - Trading window closed from 1 April 2026 until 48 hours after FY26 audited results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f32562de-771b-4859-8d40-738f9b4885df.pdf) |
| 2 Apr - Company received SEBI SAST disclosures from promoters and promoter group as on 01.04.2026. | [Disclosures Under Regulation 30(1) And 30(2) Of SEBI (Substantial Acquisition Of Shares &Takeovers) Regulations, 2011 2 Apr - Company received SEBI SAST disclosures from promoters and promoter group as on 01.04.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1ae4bd78-45e4-4583-a6b3-4a754cd4cb92.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/295baf02-4706-4ceb-bc68-4a9575938e70.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3dd3e67c-360d-488d-894b-e2fa4b0bfe2d.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9439b195-8b05-41ac-85a7-9ae7e5d7954d.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/544b4531-2eb0-4570-b3c5-ecd35ece9752.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7f15efa0-ea8d-4c56-b40e-71649e819c52.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1299b739-2df1-4397-a923-7a6c04dd3634.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/435c5e55-49c3-487b-aa43-9cd7c5cf1165.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543271/75802543271.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531762/73943531762.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/543271/70314543271.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87882348-06cb-4d9e-9bb5-c38ec625b549.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c8da205-36d5-495c-a7c9-b5e1f6767c47.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3592b361-cb1a-48a5-af26-5c9f931283dc.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7f29567b-1510-417e-bcfd-5600391303d6.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1bf562a4-5c34-43e7-ba50-021c85f3b2cf.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cd0157f-efef-454c-ae4d-6172d2b0d7ed.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b26c8b9-8bda-44a0-a673-8171e5584ee7.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b95dac65-0f9a-4825-a761-7b76ffa7663c.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be8d2916-fd1a-49b9-bf7d-5ab274eeb700.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/994e21f3-ece0-43ca-a54d-6ba45326022f.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:40:13.312Z.